Regarding antihypertensive tablets standardization

Authors

  • N. V. Parnyuk Zaporizhzhia State Medical University,

DOI:

https://doi.org/10.14739/2409-2932.2015.3.52619

Keywords:

1, 2, 4-triazole, Tablets, Analysis, Spectrophotometry

Abstract

Hypertension is one of the most important problems of medicine related to its prevalence, late diagnosis and inefficient treatment. Antihypertensive treatment is the most effective way to prevent cardiovascular complications and reduce mortality. Most drugs for the treatment of cardiovascular diseases are used in tablet form. So rational dosage form namely tablets has been created for this new drug, namely bromide 1-(β-phenylethyl)-4-amino-1,2,4-triazole.

The aim of our study was to develop methods for standardization, in particular quantitation of the content of bromide 1-(β-phenylethyl-4-amino-1,2,4-triazole in obtained tablets by spectrophotometric method.

Methods and results. We have investigated tablets containing 20 mg of active substance obtained in the laboratory and conducted six experiments. As a result, the obtained tablets containing the active substance meet the requirements of the State Pharmacopoeia of Ukraine.

Conclusion.  Our method of quantitation of the content of active substance in bromide 1-(β-phenylethyl)-4-amino-1,2,4-triazole tablets by spectrophotometric method is convenient and simple in execution, accurate and reproducible and is proposed for Drug master file.

References

Belenichev, I. F., Kucherenko, L. I., Volchik, Yu. A., Abramov, A. V., & Bukhtiyarova, N. V. Nekotorye aspekty kardioprotektornogo dejstviya novogo β-adrenoblokatora s NO-mimeticheskim e′ffektom «Gipertril» na modeli infarkta miokarda [Some aspects of cardioprotective activity of new b-adrenoblocker with NO-mimetic effect «Hypertril» on myocardial infarction model]. Farmakologiya ta likarska toksikolohiia, 4–5(40), 11–16. [in Ukrainian].

Georgievskij, G. V. (2011) Razrabotka kompleksa fiziko-khimicheskikh metodik, obespechivayuschikh sozdanie i kontrol' kachestva original'nykh otechestvennykh preparatov, proizvodnykh 1,2,4-triazola [Development of the complex physical and chemical methods, ensuring the creation and control of the quality of the original domestic products, 1,2,4-triazole]. Zaporozhskiy medicinskij zhurnal, 13(1), 58–69. [in Ukrainian].

(2008) Derzhavna Farmakopeia Ukrainy [State Ukrainian Pharmacopeia]. Kharkiv, 2, 620. [in Ukrainian].

Kucherenko, L. I., Parniuk, N. V., Moriak, Z. B. (2015) Rozrobka metodyky kilkisnoho vyznachennia dlia postadiinoho kontroliu vyrobnytstva tabletok «Hipertryl» [Development of quantitative determination methods for the stepwise control of «Hypertril» tablets production]. Farmatsevtychnyi chasopys, 2, 60–63. [in Ukrainian].

Mazur, I. A, Belenichev, I. F., Chekman, I. S., et al. (patentee) (2014) Patent 2532394 Rossijskaya Federaciya. MPK A61K31/4196 (2006.01) A61P9/10 (2006.01) A61P43/00 (2006.01). Primenenie bromida 1-(beta-feniljetil)-4-amino-1,2,4-triazolija (Gipertril) kak aktivnoj osnovy lekarstvennykh sredstv dlya korrekcii narushenij funkcionirovaniya nitroksidergicheskoj sistemy organov-mishenej pri gomocisteinemii i ostrykh narusheniya mozgovogo kroobrascheniya [Patent RU 2532394. Using 1-(β-phenylethyl)-4-amino-1,2,4-triazolium bromide (Hypertril) as an active base of drug preparations for correcting dysfunctions of the nitroxydergic system of target organs accompanying homocysteinemia and acute cerebrovascular disorders]. [in Russian].

Mazur, I. A, Belenichev, I. F., Chekman, I. S., et al. (patentee) (2013) Patent 84351 Ukraina. MPK A61K 31/41 (2006.01), A61P 9/10 (2006.01). Zastosuvannia bromidu 1-(β-feniletyl)-4-amino-1,2,4-tryazoliiu yak aktyvnoi osnovy likarskykh zasobiv dlia korektsii porushen funktsionuvannia nitroksyderhichnoi systemy pry aterosklerozi i tsukrovomu diabeti [Patent UA 84351. Using of 1-(β-phenylethyl)-4-amino-1,2,4-triazolium bromide as an active bast of medical agents for correction of nitroxidergic system dysfunction atherosclerosis and diabetes mellitus]. [in Ukrainian].

Mazur, I. A., Chekman, I. S., Belenichev, I. F., & Voloshin, N. A. (2007) Metabolitotropnye preparaty [Metabolitotropnye drugs]. Zaporozh′e. [in Ukrainian].

(2007) European Pharmacopoeia. Strasbourg.

Ulu, S.T., & Elmali, F. T. (2010) Spectrophotometric method for the determination, validation, spectroscopic and thermal analysis of diphenhydramine in pharmaceutical preparation. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy , 77, 324–329. doi: 10.1016/j.saa.2010.05.031.

White, W. (2011) Blood pressure monitoring in cardiovascular medicine and therapeutics. New Jersey: Humana Press.

Downloads

How to Cite

1.
Parnyuk NV. Regarding antihypertensive tablets standardization. Current issues in pharmacy and medicine: science and practice [Internet]. 2015Nov.3 [cited 2024Apr.25];(3). Available from: http://pharmed.zsmu.edu.ua/article/view/52619

Issue

No. 3 (2015)

Section

Analysis and standardization of biologycally active substances and dosage forms

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.     Лицензия Creative Commons
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
    3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)